Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia

Am J Hematol. 2009 Dec;84(12):849-50. doi: 10.1002/ajh.21548.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine Nucleotides / administration & dosage
  • Aminoglycosides / administration & dosage
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD / analysis
  • Antigens, Differentiation, Myelomonocytic / analysis
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Arabinonucleosides / administration & dosage
  • Asparaginase / administration & dosage
  • Bone Marrow / pathology
  • Bone Marrow Transplantation
  • Clofarabine
  • Combined Modality Therapy
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Gemtuzumab
  • Humans
  • Male
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / surgery
  • Prednisone / administration & dosage
  • Remission Induction
  • Salvage Therapy*
  • Sialic Acid Binding Ig-like Lectin 3
  • Transplantation, Homologous
  • Treatment Outcome
  • Vincristine / administration & dosage
  • Young Adult

Substances

  • Adenine Nucleotides
  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Arabinonucleosides
  • CD33 protein, human
  • Sialic Acid Binding Ig-like Lectin 3
  • Cytarabine
  • Vincristine
  • Clofarabine
  • Gemtuzumab
  • Asparaginase
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • PVDA protocol